I have been recently bullish on Apollo Endoscopy (APEN), because of it's ability to hold above the 200-day simple moving average(SMA) this year. For me, this showed that the market was ready to establish the 2017 price action as a price bottom. Still, there was a common resistance around $7.05 a share.
Apollo Endoscopy (APEN) to Challenge the Bullish Scenario
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться